Supplement Library
Individual Article: Updated Review of Topical Pharmaceuticals and Complementary and Alternative Medications for the Treatment of Onychomycosis in Both General and Special Populations in the United States
September 2023 | Volume 22 | Issue 9 | Supplement Individual Articles | SF378719 | Copyright © September 2023
Onychomycosis is a prevalent condition affecting the United States and global population. Treatment options are limited, with only 3 topical anti-fungal medications garnering approval in the US w...
Read MoreFULL SUPPLEMENT: Management of Atopic Dermatitis in People with Skin of Color: A Practical Algorithm
August 2023 | Volume 22 | Issue 8 | Department | SF386361s1 | Copyright © August 2023
Background: Variations in the epidemiology, clinical presentation, and disease course in skin of color (SOC) atopic dermatitis (AD) patients have been reported that may impact treatme...
Read MoreFULL SUPPLEMENT: Fixed Combination Calcipotriene/Betamethasone (Cal/BDP) Cream: Evaluating the Role of Polyaphron Dispersion (PAD) Technology in Psoriasis Treatment
August 2023 | Volume 22 | Issue 8 | Department | SF381621s1 | Copyright © August 2023
Most patients with plaque psoriasis exhibit mild-to-moderate disease and topical therapies remain the mainstay treatment option for these patients. The use of topical steroids in combination with vita...
Read MoreINDIVIDUAL ARTICLE: An Algorithm for the Management of Atopic Dermatitis in People With Skin of Color
August 2023 | Volume 22 | Issue 8 | Supplement Individual Articles | SF386361s3 | Copyright © August 2023
Background: Variations in the epidemiology, clinical presentation, and disease course in skin of color (SOC) atopic dermatitis (AD) patients have been reported that may impact tr...
Read MoreINDIVIDUAL ARTICLE: Fixed Combination Calcipotriene/Betamethasone (Cal/BDP) Cream: Evaluating the Role of Polyaphron Dispersion (PAD) Technology in Psoriasis Treatment
August 2023 | Volume 22 | Issue 8 | Supplement Individual Articles | SF381621s5 | Copyright © August 2023
Most patients with plaque psoriasis exhibit mild-to-moderate disease and topical therapies remain the mainstay treatment option for these patients. The use of topical steroids in combination with...
Read MoreIndividual Article: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne
June 2023 | Volume 22 | Issue 6 | Supplement Individual Articles | SF350992s7 | Copyright © June 2023
Acne is a prevalent chronic inflammatory disease that can cause severe psychiatric effects and physical scarring of the skin. Historically, although systemic antiandrogen acne medications have be...
Read MoreFULL SUPPLEMENT: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne
June 2023 | Volume 22 | Issue 6 | Department | SF350992s5 | Copyright © June 2023
Acne is a prevalent chronic inflammatory disease that can cause severe psychiatric effects and physical scarring of the skin. Historically, although systemic antiandrogen acne medications have be...
Read MoreSupplement Individual Article: Chelating Agents in Skincare: Comprehensive Protection Against Environmental Aggressors
May 2023 | Volume 22 | Issue 5 | Supplement Individual Articles | SF383499s5 | Copyright © May 2023
In addition to ultraviolet light, skin is regularly exposed to several environmental stressors that can cause damage and premature aging. Particulate matter in the environment, including transiti...
Read MoreFULL SUPPLEMENT: Environmental Aggressors And Comprehensive Protection: Chelating Agents In Skincare
May 2023 | Volume 22 | Issue 5 | Department | SF383499s4 | Copyright © May 2023
ENVIRONMENTAL AGGRESSORS AND COMPREHENSIVE PROTECTION: CHELATING AGENTS IN SKINCARE(BASED ON A MEDSCAPE EDUCATION ONLINE ACTIVITY)...
Read MoreFULL SUPPLEMENT: A Review and Consensus on Promoting Skin Barrier Health Throughout Life Using Ceramide-Containing Skin Care
February 2023 | Volume 22 | Issue 2 | Department | SF3446071 | Copyright © February 2023
Adjunctive daily skin care throughout life promotes a healthy skin barrier and is beneficial in managing various inflammatory skin disorders in all populations. However, when choosing optimal treatmen...
Read MoreSupplement Individual Article: The Importance of a Healthy Skin Barrier From the Cradle to the Grave Using Ceramide-Containing Cleansers and Moisturizers: A Review and Consensus
February 2023 | Volume 22 | Issue 2 | Supplement Individual Articles | SF344607s3 | Copyright © February 2023
Introduction: Inflammatory skin disorders compromise skin barrier health. Early and daily skincare use aims to maintain a life-long healthy skin barrier. Racial/ethnic and age variati...
Read MoreSupplement Individual Article: Pediatric Acne Patients' Treatment Real-World Case Series Using Skincare as Monotherapy, Adjunctive, and Maintenance Treatment
February 2023 | Volume 22 | Issue 2 | Supplement Individual Articles | SF376527s3 | Copyright © February 2023
Background: Pediatric acne is a common, complex, multifactorial inflammatory skin disease with various expressions in childhood that can be categorized by age, severity, and pubertal ...
Read MoreFULL SUPPLEMENT: Pediatric Acne Patient Cases to Tailor Skincare as Monotherapy, Adjunctive, and Maintenance treatment
February 2023 | Volume 22 | Issue 2 | Department | SF376527s1 | Copyright © February 2023
Adjunctive daily skin care throughout life promotes a healthy skin barrier and is beneficial in managing various inflammatory skin disorders in all populations. However, when choosing optimal treatmen...
Read MoreSupplement Individual Article: NECOM Skincare Algorithm for Patients With Cancer and Survivors
January 2023 | Volume 22 | Issue 1 | Supplement Individual Articles | 3595573 | Copyright © January 2023
Background: Cancer treatment-related cutaneous adverse events (cAEs) frequently occur, which can interfere with anticancer treatment outcomes and can severely impact quality of life f...
Read MoreFULL SUPPLEMENT: Nordic European Cutaneous Oncodermatology Management (NECOM ) 2: Skincare For Patients With Cancer in Scandinavia
January 2023 | Volume 22 | Issue 1 | Department | 3595571 | Copyright © January 2023
The NECOM panel discussed and reached a consensus on an evidence- and opinion-based practical algorithm for oncology skin care to support all stakeholders in the Nordic European health care setting. T...
Read MoreSupplement Individual Article: Oldie But Goodie
January 2023 | Volume 22 | Issue 1 | Supplement Individual Articles | 3446172 | Copyright © January 2023
Research over the past several years has elucidated the pathophysiology of psoriasis, yielding both new treatment options and enhanced knowledge of the mechanisms of action of existing treatments....
Read MoreSupplement Individual Article: A Reappraisal of Fixed-Combination Halobetasol Propionate and Tazarotene for the Treatment of Psoriasis: Biological Underpinnings, Therapeutic Mechanisms, and Economic Considerations
January 2023 | Volume 22 | Issue 1 | Supplement Individual Articles | 3446174 | Copyright © January 2023
Psoriasis is a complex inflammatory disease, which can be triggered by the interplay among keratinocytes, various immune cells, and even dermal vascular endothelial cells. Understanding of the key pla...
Read MoreFULL SUPPLEMENT: TAZAROTENE AND PSORIASIS: BIOLOGIC UNDERPINNINGS THAT IMPACT DISEASE CONTROL
January 2023 | Volume 22 | Issue 1 | Department | 3446171 | Copyright © January 2023
Fixed-combination HP 0.01%/TAZ 0.045% lotion is a single treatment that packs a "one-two punch" in terms of clinical efficacy and economic benefit. Given the excellent safety profile, limited contrain...
Read MoreSUPPLEMENT INDIVIDUAL ARTICLES: Update on Truncal Acne: A Review of Treatments for a Neglected Disease and the Re-Emergence of Tazarotene
December 2022 | Volume 21 | Issue 12 | Supplement Individual Articles | SF3446185 | Copyright © December 2022
Acne vulgaris of the trunk carries with it a major psychosocial impact and an unmet need for adequate management. Approximately 50% of patients with facial acne also exhibit involvement of the back, c...
Read MoreSUPPLEMENT INDIVIDUAL ARTICLES: "Vehicles Matter" in the Treatment of Truncal Acne
December 2022 | Volume 21 | Issue 12 | Supplement Individual Articles | SF3446183 | Copyright © December 2022
Among the general population and arguably among most dermatologists, the word acne calls to mind images of a teenager with papules and pustules on the face. Yet, we know that acne is not just a diseas...
Read More